| 1 |
Hagemann AR, Nikam R, Mutch DG. Genes and cancer: Genetic counselling and clinical management. DiSaia and Creasman Clinical Gynecologic Oncology 2023. [DOI: 10.1016/b978-0-323-77684-4.00027-1] [Reference Citation Analysis]
|
| 2 |
Mutlu L, Manavella DD, Gullo G, Mcnamara B, Santin AD, Patrizio P. Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes. Cancers 2022;14:5187. [DOI: 10.3390/cancers14215187] [Reference Citation Analysis]
|
| 3 |
Holter S, Hall MJ, Hampel H, Jasperson K, Kupfer SS, Larsen Haidle J, Mork ME, Palaniapppan S, Senter L, Stoffel EM, Weissman SM, Yurgelun MB. Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer. J Genet Couns 2022. [PMID: 35001450 DOI: 10.1002/jgc4.1546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Makabe T, Yamagami W, Hirasawa A, Miyabe I, Wakatsuki T, Kikuchi M, Takahashi A, Noda J, Yamamoto G, Aoki D, Akagi K. Incidence of germline variants in Lynch syndrome-related genes among Japanese endometrial cancer patients aged 40 years or younger. Int J Clin Oncol 2021;26:1767-74. [PMID: 34115236 DOI: 10.1007/s10147-021-01953-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Huang M, Hunter T, Fein LA, Galli J, George S, Schlumbrecht M, McCarter K, Sinno AK, Guido LP, Pinto A. Lost opportunities for mismatch repair (MMR) screening among minority women with endometrial cancer. Sci Rep 2021;11:11712. [PMID: 34083606 DOI: 10.1038/s41598-021-91053-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Stinton C, Jordan M, Fraser H, Auguste P, Court R, Al-Khudairy L, Madan J, Grammatopoulos D, Taylor-Phillips S. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation. Health Technol Assess 2021;25:1-216. [PMID: 34169821 DOI: 10.3310/hta25420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Manchana T, Ariyasriwatana C, Triratanachat S, Phowthongkum P. Lynch Syndrome in Thai Endometrial Cancer Patients. Asian Pac J Cancer Prev 2021;22:1477-83. [PMID: 34048176 DOI: 10.31557/APJCP.2021.22.5.1477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Pauly N, Baert T, Schmutzler R, du Bois A, Schneider S, Rhiem K, Schömig-Markiefka B, Siemanowski J, Heikaus S, Traut A, Heitz F, Prader S, Ehmann S, Harter P, Ataseven B. Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience. Arch Gynecol Obstet 2021;304:975-84. [PMID: 33710393 DOI: 10.1007/s00404-021-06006-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Gallon R, Gawthorpe P, Phelps RL, Hayes C, Borthwick GM, Santibanez-Koref M, Jackson MS, Burn J. How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies. Cancers (Basel) 2021;13:406. [PMID: 33499123 DOI: 10.3390/cancers13030406] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 10 |
Schrader EA, Paterniti TA, Ahmad S. Lifestyle, nutrition, and risk of gynecologic cancers. Overcoming Drug Resistance in Gynecologic Cancers 2021. [DOI: 10.1016/b978-0-12-824299-5.00019-8] [Reference Citation Analysis]
|
| 11 |
Adefuye P, Olawaiye A. Cancer of the Uterine Corpus. Contemporary Obstetrics and Gynecology for Developing Countries 2021. [DOI: 10.1007/978-3-030-75385-6_57] [Reference Citation Analysis]
|
| 12 |
Gordhandas S, Kahn RM, Gamble C, Talukdar N, Maddy B, Baltich Nelson B, Askin G, Christos PJ, Holcomb K, Caputo TA, Chapman-Davis E, Frey MK. Clinicopathologic features of endometrial cancer with mismatch repair deficiency. Ecancermedicalscience 2020;14:1061. [PMID: 32582376 DOI: 10.3332/ecancer.2020.1061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 13 |
Paterniti TA, Schrader EA, Deibert E, Wilkinson EA, Ahmad S. Changing Trends in the Epidemiology of Endometrial Cancer. Recent Advances in Endometrial Cancer 2020. [DOI: 10.1007/978-981-15-5317-2_1] [Reference Citation Analysis]
|
| 14 |
Snowsill TM, Ryan NAJ, Crosbie EJ, Frayling IM, Evans DG, Hyde CJ. Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting. PLoS One. 2019;14:e0221419. [PMID: 31469860 DOI: 10.1371/journal.pone.0221419] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Ryan NAJ, Glaire MA, Blake D, Cabrera-Dandy M, Evans DG, Crosbie EJ. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Genet Med 2019;21:2167-80. [PMID: 31086306 DOI: 10.1038/s41436-019-0536-8] [Cited by in Crossref: 89] [Cited by in F6Publishing: 96] [Article Influence: 22.3] [Reference Citation Analysis]
|
| 16 |
Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM, Crawford R, Eccles D, Frayling IM, Ghaem-Maghami S, Hampel H, Kauff ND, Kitchener HC, Kitson SJ, Manchanda R, McMahon RFT, Monahan KJ, Menon U, Møller P, Möslein G, Rosenthal A, Sasieni P, Seif MW, Singh N, Skarrott P, Snowsill TM, Steele R, Tischkowitz M, Evans DG; Manchester International Consensus Group. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med 2019;21:2390-400. [PMID: 30918358 DOI: 10.1038/s41436-019-0489-y] [Cited by in Crossref: 93] [Cited by in F6Publishing: 99] [Article Influence: 23.3] [Reference Citation Analysis]
|
| 17 |
Yadav G, Singla A. Hereditary Endometrial and Ovarian Cancers. Preventive Oncology for the Gynecologist 2019. [DOI: 10.1007/978-981-13-3438-2_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 18 |
Özdemir TR, Alan M, Sancı M, Koç A. Targeted Next-Generation Sequencing of MLH1, MSH2, and MSH6 Genes in Patients with Endometrial Carcinoma under 50 Years of Age. Balkan Med J 2019;36:37-42. [PMID: 30238922 DOI: 10.4274/balkanmedj.2018.0922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 19 |
Mutch DG, Babb SA, Di Saia PJ. Genes and Cancer. Clinical Gynecologic Oncology 2018. [DOI: 10.1016/b978-0-323-40067-1.00019-x] [Reference Citation Analysis]
|
| 20 |
Mok SC, Wong K, Lu KH, Munger K, Nagymanyoki Z. Molecular Basis of Gynecologic Diseases. Molecular Pathology 2018. [DOI: 10.1016/b978-0-12-802761-5.00023-7] [Reference Citation Analysis]
|
| 21 |
Pokharel HP, Hacker NF, Andrews L. Genetic testing in a gynaecological oncology care in developing countries-knowledge, attitudes and perception of Nepalese clinicians. Gynecol Oncol Res Pract 2016;3:12. [PMID: 27980798 DOI: 10.1186/s40661-016-0034-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 22 |
Kast K, Dobberschütz C, Sadowski CE, Pistorius S, Wimberger P. Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer. Arch Gynecol Obstet 2016;294:1299-303. [PMID: 27535758 DOI: 10.1007/s00404-016-4180-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 23 |
Khanna N, Berek JS. Cancer genetics. Clinical Gynecology 2015. [DOI: 10.1017/cbo9781139628938.056] [Reference Citation Analysis]
|
| 24 |
Gynecological oncology. Clinical Gynecology 2015. [DOI: 10.1017/cbo9781139628938.045] [Reference Citation Analysis]
|
| 25 |
Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol 2014;38:1501-9. [PMID: 25229768 DOI: 10.1097/PAS.0000000000000321] [Cited by in Crossref: 170] [Cited by in F6Publishing: 177] [Article Influence: 18.9] [Reference Citation Analysis]
|
| 26 |
Bharati R, Jenkins MA, Lindor NM, Le Marchand L, Gallinger S, Haile RW, Newcomb PA, Hopper JL, Win AK. Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer? Gynecol Oncol 2014;133:287-92. [PMID: 24631449 DOI: 10.1016/j.ygyno.2014.03.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 27 |
Heo EJ, Park JM, Lee EH, Lee HW, Kim MK. A Case of Perimenopausal Endometrial Cancer in a Woman with MSH2 Germline Mutation. J Menopausal Med 2013;19:143-6. [PMID: 25371881 DOI: 10.6118/jmm.2013.19.3.143] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. J Clin Oncol 2014;32:90-100. [PMID: 24323032 DOI: 10.1200/JCO.2013.51.2129] [Cited by in Crossref: 143] [Cited by in F6Publishing: 152] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 29 |
Stewart A Phd. Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives. PLoS Curr 2013;5:ecurrents. [PMID: 24056992 DOI: 10.1371/currents.eogt.b59a6e84f27c536e50db4e46aa26309c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 30 |
Masuda K, Banno K, Hirasawa A, Yanokura M, Tsuji K, Kobayashi Y, Kisu I, Ueki A, Nomura H, Tominaga E, Susumu N, Aoki D. Relationship of lower uterine segment cancer with Lynch syndrome: a novel case with an hMLH1 germline mutation. Oncol Rep 2012;28:1537-43. [PMID: 22940821 DOI: 10.3892/or.2012.2008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 31 |
Clarke BA, Cooper K. Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas. Adv Anat Pathol 2012;19:231-8. [PMID: 22692286 DOI: 10.1097/PAP.0b013e31825c6b76] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 32 |
Lynch syndrome (hereditary non-polyposis colorectal cancer syndrome). Uterine Pathology 2012. [DOI: 10.1017/cbo9780511978104.020] [Reference Citation Analysis]
|
| 33 |
Mehasseb MK, Latimer JA. Controversies in the management of endometrial carcinoma: an update. Obstet Gynecol Int 2012;2012:676032. [PMID: 22518164 DOI: 10.1155/2012/676032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 34 |
Mutch DG, Di Saia PJ. Genes and Cancer. Clinical Gynecologic Oncology 2012. [DOI: 10.1016/b978-0-323-07419-3.00019-9] [Reference Citation Analysis]
|
| 35 |
Uccella S, Cha SS, Melton LJ, Bergstralh EJ, Boardman LA, Keeney GL, Podratz KC, Ciancio FF, Mariani A. Risk factors for developing multiple malignancies in patients with endometrial cancer. Int J Gynecol Cancer. 2011;21:896-901. [PMID: 21666488 DOI: 10.1097/igc.0b013e318219711f] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 36 |
Kwon JS, Scott JL, Gilks CB, Daniels MS, Sun CC, Lu KH. Testing women with endometrial cancer to detect Lynch syndrome. J Clin Oncol 2011;29:2247-52. [PMID: 21537049 DOI: 10.1200/JCO.2010.32.9979] [Cited by in Crossref: 82] [Cited by in F6Publishing: 89] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 37 |
Pino MS, Chung DC. Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn. 2010;10:651-665. [PMID: 20629513 DOI: 10.1586/erm.10.45] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 38 |
Cossio SL, Koehler-Santos P, Pessini SA, Mónego H, Edelweiss MI, Meurer L, Errami A, Coffa J, Bock H, Saraiva-Pereira ML, Ashton-Prolla P, Prolla JC. Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil. Fam Cancer 2010;9:131-9. [PMID: 19821155 DOI: 10.1007/s10689-009-9297-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 39 |
Gayther SA, Pharoah PD. The inherited genetics of ovarian and endometrial cancer. Curr Opin Genet Dev 2010;20:231-8. [PMID: 20456938 DOI: 10.1016/j.gde.2010.03.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 40 |
Walsh CS, Blum A, Walts A, Alsabeh R, Tran H, Koeffler HP, Karlan BY. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening. Gynecol Oncol. 2010;116:516-521. [PMID: 20034658 DOI: 10.1016/j.ygyno.2009.11.021] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 41 |
Davidson SA. Hereditary Gynecologic Cancer Syndromes. Postgraduate Obstetrics & Gynecology 2010;30:1-7. [DOI: 10.1097/01.pgo.0000364891.73439.70] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 42 |
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AH, Cartwright NR, Barnetson RA, Farrington SM. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010;102:193-201. [PMID: 20028993 DOI: 10.1093/jnci/djp473] [Cited by in Crossref: 261] [Cited by in F6Publishing: 283] [Article Influence: 18.6] [Reference Citation Analysis]
|
| 43 |
Hanson H, Hodgson S. Cancer genetics and reproduction. Best Pract Res Clin Obstet Gynaecol 2010;24:3-18. [PMID: 19864186 DOI: 10.1016/j.bpobgyn.2009.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 44 |
Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control 2009;16:14-22. [PMID: 19078925 DOI: 10.1177/107327480901600103] [Cited by in Crossref: 149] [Cited by in F6Publishing: 163] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 45 |
Martín Angulo M, Martínez-amores Martínez B, Navarro Expósito F, Álvarez-mon Soto M. Cáncer de endometrio. Medicine - Programa de Formación Médica Continuada Acreditado 2009;10:1599-1605. [DOI: 10.1016/s0211-3449(09)70004-9] [Reference Citation Analysis]
|
| 46 |
Westin SN, Lacour RA, Urbauer DL, Luthra R, Bodurka DC, Lu KH, Broaddus RR. Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. J Clin Oncol 2008;26:5965-71. [PMID: 19001318 DOI: 10.1200/JCO.2008.18.6296] [Cited by in Crossref: 152] [Cited by in F6Publishing: 161] [Article Influence: 10.1] [Reference Citation Analysis]
|
| 47 |
Daniels M. Genetic Risk Assessment for Hereditary Endometrial Cancer. Hereditary Gynecologic Cancer 2008. [DOI: 10.3109/9781420052886-18] [Reference Citation Analysis]
|
| 48 |
Clinical Relevance of Hereditary Endometrial Cancer. Hereditary Gynecologic Cancer 2008. [DOI: 10.3109/9781420052886-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 49 |
Matthews KS, Estes JM, Conner MG, Manne U, Whitworth JM, Huh WK, Alvarez RD, Straughn JM Jr, Barnes MN, Rocconi RP. Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet Gynecol 2008;111:1161-6. [PMID: 18448750 DOI: 10.1097/AOG.0b013e31817051d9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 50 |
Garca Mat J, Lpez M, Prez Lpez M, Garca Gmez J. C?ncer de ?tero. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 2005;9:1675-1680. [DOI: 10.1016/s0211-3449(05)73533-5] [Reference Citation Analysis]
|
